Loss of Heterozygosity and Promoter Methylation, but not Mutation, May Underlie Loss of TFF1 in Gastric Carcinoma
- 1 October 2002
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 82 (10) , 1319-1326
- https://doi.org/10.1097/01.lab.0000029205.76632.a8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Refined Localization of Autosomal Recessive Nonsyndromic Deafness DFNB10 Locus Using 34 Novel Microsatellite Markers, Genomic Structure, and Exclusion of Six Known Genes in the RegionGenomics, 2000
- DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesisCancer Letters, 2000
- Trefoil peptidesGut, 1999
- Hepatocyte Nuclear Factor 3 (Winged Helix Domain) Activates Trefoil Factor Gene TFF1 through a Binding Motif Adjacent to the TATAA BoxDNA and Cell Biology, 1999
- pS2 Protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric studyEuropean Journal Of Cancer, 1996
- Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosaEuropean Journal Of Cancer Prevention, 1996
- Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude miceVirchows Archiv, 1996
- Genomic sequencing indicates a correlation between DNA hypomethylation in the 5′ region of the pS2 gene and its expression in human breast cancer cell linesGene, 1995
- Characterization of four new gastric cancer cell linesVirchows Archiv B Cell Pathology Including Molecular Pathology, 1993
- A new family of growth factor‐like peptides ‘Trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins)FEBS Letters, 1989